Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT

Clinical trial NCT04127396 · UNKNOWN

Trial details

NCT number: NCT04127396
Sponsor: Beijing Ditan Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular Portal Vein Tumor Thrombus

Start date: 2019-09-01
Primary completion: 2021-08-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.